Keywords: zenapax, approved, switzerland, hoffmann-la, roche, daclizumab, been

Zenapax Approved In Switzerland

Article | 05 March 1998

Hoffmann-La Roche's Zenapax (daclizumab) has been approved bySwitzerland's Intercantonal Office for the Control of Medicines for the prophylaxis of acute ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Roche

Go to company listing

Related Drugs

Daclizumab

Zenapax

Go to drug listing